We are into the business of pharmaceuticals - exporting human drugs including materials and machineries required to produce the same.
We are mainly focussed in Central Africa, where we have significant presence in the fast growing specialty therapeutic segments of Anti- malarial, Anti-inflammatory, anti- fungal, cardiovascular, ophthalmology and musculoskeletal.We have good expertise to manufacture tablets, capsules, syrups, ointments, sterile powder injectables & liquid injectables. Our products are manufactured in the state-of-the art facilities that produce high quality products. We focus on commercializing unique generic products and pioneering synergistic combination products in the therapeutic areas.
With primary focus on new product innovation and introduction, We have been consistently identifying unmet medical needs and introducing many first-to-market products to cater to those needs. Our products provide patient compliance and convenience over existing therapeutic options. Gaining first mover advantage, many of our brands hold leadership positions in their respective sub- therapeutic segments.
Animal Health : Earlier, we had business of manufacturing and marketing veterinary drugs and feed products. This business was sold to Merial, a Sanofi group company in 2013.